The DDAH2 expression tended to be less decreased in N1/N2 than N0 cancers (by 1.5-fold, p = 0.059) and stage III/IV than 0/I/II cancers (by 1.5-fold, p = 0.058) (Figure S3). The gene discussed is DDAH2; the disease is cancer.